TrendForce independently projects that HBM will consume 30% of total DRAM wafer capacity by 2027, leaving supply able to meet only 60% of projected demand, with UBS forecasting supply-demand balance no earlier than Q2 2028 . Micron has locked 16 companies into five-year supply contracts, and new fab capacity from any manufacturer won't ship meaningful volume until at least mid-2027
.
The core mechanism is a structural reallocation. Samsung, SK hynix, and Micron are diverting production lines from commodity DDR4/DDR5 and LPDDR5X toward high-margin HBM used in Nvidia's AI accelerators . Unlike the pandemic-era chip shortage, this one is driven by AI data-center spending that is price-inelastic and structurally reallocating global fab capacity away from consumer devices
.
Apacer CEO C.K. Chang warned that memory suppliers may release less than 30% of their 2026 supply volumes to the open market in 2027, leaving module makers and traditional memory buyers competing for limited inventory .
DRAM prices have climbed at an extraordinary pace:
In a striking signal of supply severity, Nvidia itself is being forced to compromise. TrendForce reported in early August 2026 that, since Q3 2026, Nvidia has expanded its evaluation of the Rubin Ultra AI platform beyond the originally planned 12-Hi HBM4e configuration to include 8-Hi HBM4e, 12-Hi HBM4, and 8-Hi HBM4 alternatives — all lower-spec memory configurations — due to persistent HBM supply tightness and uncertainty over suppliers' HBM4e validation timelines .
Some reports indicate the Rubin Ultra's memory may be cut to 192GB, down from earlier targets . Nvidia also recently downgraded its Vera Rubin Superchip due to LPDDR5X shortages
.
Several analysts and outlets have noted that Samsung, SK hynix, and Micron — which control roughly 95% of the global DRAM market — have little incentive to rapidly expand consumer-grade capacity when AI HBM commands far higher margins . The Register and others pointed out the apparent conflict: Samsung warns of a worsening crunch while simultaneously reporting record profits and a 52% operating margin
. Some experts argue the shortage is being prolonged by deliberate capacity discipline rather than genuine physical constraints
.
The DRAM industry has a history of cartel behavior (the 2000s price-fixing conspiracy resulted in billions in fines and prison sentences), and the current triopoly structure naturally raises concern. However, the sourced reports capture industry skepticism and accusations rather than confirmed regulatory action. No active formal antitrust investigations or cartel proceedings against the DRAM manufacturers have been confirmed in the available sources as of mid-2026.